Northland Capmk Forecasts Abacus Life Q1 Earnings

Key Points

• Northland Capmk forecasts Abacus Life's Q1 2026 earnings at $0.22 per share, with a full-year estimate of $0.62 per share, reflecting positive growth expectations.
• The stock received a new price target from Piper Sandler, reducing it from $12.00 to $10.00, while Wall Street Zen upgraded it from "hold" to "buy" rating.
• Abacus Life's recent quarterly earnings exceeded expectations with an EPS of $0.22 against a consensus of $0.16, alongside revenue of $56.23 million versus an anticipated $43.38 million.

Abacus Life, Inc. (NASDAQ:ABL - Free Report) - Stock analysts at Northland Capmk issued their Q1 2026 EPS estimates for Abacus Life in a research report issued to clients and investors on Tuesday, September 9th. Northland Capmk analyst M. Grondahl expects that the company will post earnings of $0.22 per share for the quarter. The consensus estimate for Abacus Life's current full-year earnings is $0.62 per share. Northland Capmk also issued estimates for Abacus Life's Q2 2026 earnings at $0.25 EPS, Q3 2026 earnings at $0.27 EPS, Q4 2026 earnings at $0.28 EPS and FY2026 earnings at $1.02 EPS.

Other equities analysts also recently issued research reports about the stock. Wall Street Zen raised shares of Abacus Life from a "hold" rating to a "buy" rating in a research note on Saturday, August 9th. Piper Sandler reduced their price objective on shares of Abacus Life from $12.00 to $10.00 and set an "overweight" rating for the company in a research note on Wednesday, July 2nd. One research analyst has rated the stock with a Strong Buy rating and four have given a Buy rating to the company's stock. According to MarketBeat, Abacus Life has an average rating of "Buy" and a consensus price target of $13.13.

Abacus Life Stock Up 0.6%

NASDAQ:ABL traded up $0.04 during trading hours on Thursday, reaching $6.71. The company's stock had a trading volume of 184,527 shares, compared to its average volume of 595,250. The company has a market capitalization of $649.26 million, a P/E ratio of -110.75 and a beta of 0.02. Abacus Life has a 12 month low of $4.60 and a 12 month high of $10.95. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.76 and a current ratio of 0.76. The stock has a 50 day moving average price of $5.96 and a two-hundred day moving average price of $6.83.

Abacus Life (NASDAQ:ABL - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The company reported $0.22 EPS for the quarter, topping analysts' consensus estimates of $0.16 by $0.06. The company had revenue of $56.23 million during the quarter, compared to the consensus estimate of $43.38 million. Abacus Life had a negative net margin of 0.72% and a positive return on equity of 17.65%.

Hedge Funds Weigh In On Abacus Life

Several hedge funds have recently made changes to their positions in ABL. AlphaQuest LLC acquired a new position in shares of Abacus Life in the 2nd quarter valued at $25,000. Darwin Wealth Management LLC acquired a new position in shares of Abacus Life in the 2nd quarter valued at $27,000. Raymond James Financial Inc. acquired a new position in shares of Abacus Life in the 2nd quarter valued at $34,000. Legal & General Group Plc acquired a new position in shares of Abacus Life in the 2nd quarter valued at $34,000. Finally, KLP Kapitalforvaltning AS acquired a new position in shares of Abacus Life in the 2nd quarter valued at $41,000.

Abacus Life Company Profile

Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.